Islam Elkholi retweeted
Reviewing a grant proposal online and this is the first question I'm asked. Folks, I think we solved peer review
Islam Elkholi retweeted
Headed to #AACR26, the same week we had practice changing clinical trial data in #PancreaticCancer with a KRAS inhibitor.
Reminded of this critique that @Pasca_Lab received on her grant in 2013 - "There are not, and will never be, KRAS inhibitors".
Keep calm & science on!
Islam Elkholi retweeted
نبارك اليوم للفائز بجائزة نوابغ العرب عن فئة الطب لعام 2025، الدكتور نبيل صيدح، من مصر، مدير وحدة أبحاث الغدد العصبية الحيوية في معهد مونتريال للأبحاث السريرية.
قدّم إسهامات علمية رائدة في فهم صحة القلب وتنظيم مستويات الكوليسترول، وركّز في دراساته على العمليات الحيوية التي تتحكم في كيفية تعامل الجسم مع الدهون، مما ساهم في تطوير جيل جديد من الأدوية تُستخدم اليوم على نطاق واسع لخفض الكوليسترول وتقليل مخاطر أمراض القلب. نشر أكثر من 820 بحثاً علمياً، وتمّ الاستشهاد بأبحاثه أكثر من 71 ألف مرة.
الطب رسالة إنسانية، ومنطقتنا كان لها فضل كبير، على مدى قرون، في تطوير علومه، وممارساته، وأدواته، وأبحاثه. وجائزة نوابغ العرب تعيد البوصلة إلى مسارها الصحيح، لتحتفي بما يقدّمه الإنسان العربي، وتُظهره قدوةً للأجيال.
Islam Elkholi retweeted
🔬 We have an opening for a postdoctoral fellow in my lab at Weill Cornell in NYC. This position is ideal for a rigorous, hands-on experimental biologist who loves designing and executing complex wet lab experiments. The focus is on mechanistic cancer biology in cell lines and patient-derived models, with genomics and AI tools integrating with the core bench work. Details below. 👉 Please share with strong experimental candidates in your network.
#Postdoc #PostdocJobs #AcademicJobs #CancerResearch #MolecularBiology #WetLab #ScienceCareers #AcademicTwitter
Please spread the word. We are looking for outstanding postdoctoral researchers interested in studying cancer evolution!
🌟 See our recent work nature.com/articles/s41586-0…
Details here: bit.ly/436GzMc
Islam Elkholi retweeted
I love finding a paper published years ago (5, 10, 15, 20) that isn't famous or field changing or has a ton of citations but when you read it is just awesome. Like, beautifully designed & executed & written. Best part there are so many papers like that lurking in the literature.
Islam Elkholi retweeted
Proud to share our new collaborative paper in @Dev_journal , led by Ph.D. student Sarah Nahlé!
We reveal that vertebrate myogenesis involves two transcriptionally distinct myocyte states:
Mc1 (Mymk+Mymx+)
Mc2 (Mymk+)
Read here: journals.biologists.com/dev/…
Islam Elkholi retweeted
New PI life: competing with the “big labs” for rotation students feels like bringing a salad to a pizza party. 🍕🥗 No takers this round, but we’ll keep cooking 💪— the right students will come🫵
Islam Elkholi retweeted
David Baltimore (March 7, 1938 – September 6, 2025). His discovery of reverse transcriptase, along with Howard Temin and Satoshi Mizutani, illuminated the retrovirus life cycle, led to the discovery of viral oncogenesis mechanisms and antiviral RT inhibitors, and enabled technologies including RT-PCR, RNA-seq, and prime editing.
nytimes.com/2025/09/07/scien…
Islam Elkholi retweeted
We are proud to be a founding contributor to lipidinteractome.org, a repository developed by @TheTafesseLab & Schultz lab to increase accessibility to proteomics data from multi-functionalized lipid analogs! Check out the website & preprint: arxiv.org/abs/2507.23101 #lipidtime
Islam Elkholi retweeted
Super excited to share our newest piece out today @NatureRevCancer linking age-induced metabolic reprogramming to cancer development. nature.com/articles/s41568-0…
Islam Elkholi retweeted
If you’re at #ASCO25 stop by poster 432 to chat with @iselkholi about his work on non-V600 BRAF mutant cancers!
Islam Elkholi retweeted
Online Now: Ribosomal rebellion: When protein factories drive cancer progression dlvr.it/TKMDq7
Islam Elkholi retweeted
Today we report the directed evolution of HUH (a sequence-sequence covalent protein tag for ssDNA labeling) into rHUH, a sequence-specific covalent protein tag for RNA labeling. rHUH was hard to engineer: the initial HUH template had no RNA activity, so we started with RNA-DNA hybrids. 30 rounds of selection on the yeast surface were required, and 7 cycles of library diversification.
The final rHUH tag is 13.4 kD, has 12 mutations relative to HUH, and covalently labels as little as 1 nM target RNA within minutes. The labeling works well in mammalian cell lysate, but not yet in the interior of living cells – possibly due to the high Mg2+ requirement and imperfect sequence specificity resulting in significant background labeling of endogenous transcripts.
There is still work to be done for this to be a dream tool for RNA imaging/editing/mapping in living cells, but rHUH provides a good starting point and it is definitely good enough for in vitro applications.
Congratulations to postdoc @RongbingHuang, whose creativity, persistence, and resourcefulness made rHUH possible! We are grateful to NSF and Biohub for funding this work.
pnas.org/doi/10.1073/pnas.24…
Islam Elkholi retweeted
Ahmed Zewail, the founder of femtochemistry, developed methods for studying chemical reactions in detail. He was awarded the 1999 chemistry prize "for his studies of the transition states of chemical reactions using femtosecond spectroscopy."
More at bit.ly/4b5HX4j
Islam Elkholi retweeted
Orii & Tanimoto study the structural mechanics of #microtubule and #actin cytoskeletons using high-force intracellular magnetic tweezers. hubs.la/Q036p2pL0
In #Mechanobiology 2025: hubs.la/Q036p5gc0
Islam Elkholi retweeted
ASCO24 Updates: Dr. April Rose on BEAVER Trial and New BRAF Cancer Therapies
@DrDrAprilRose @ASCO @HGJF_JGHF
OncoDaily covered the ASCO Annual Meeting in Chicago, where we had the opportunity to interview Dr. April Rose from Jewish General Hospital. She discussed the BEAVER trial results, focusing on Binimetinib and Encorafenib for advanced solid tumors with non-V600E BRAF mutations.
👉 Watch the full interview for more insights.
oncodaily.com/dialogues/asco…
#Cancer #Medicine #Health #ASCO24 #BRAF #MedEd #MedX #MedNews #CancerTreatment #Oncology #OncoDaily
Islam Elkholi retweeted
🚨 Exciting news!
We are now accepting submissions for the special collection Dormancy and Metastatic Disease, guest-edited by @luciaborriell, @FaneMitchell & @Yash_Chhabra.
📢 Submit your work and contribute to this evolving field!
@TempleUniv @katztemplemed @FoxChaseCancer @MetastasisRS @SusanGKomen
We welcome submissions to the special collection 'Dormancy and Metastatic Disease’, Guest Edited by
@luciaborriell , @FaneMitchell and @Yash_Chhabra: link.springer.com/collection…… #metastasis #dormancy
Islam Elkholi retweeted
This past week, Egypt’s Ministry of Culture declared 2025 “The Year of Umm Kulthum,” who passed away 50 years ago. In the months ahead, a “Discovering Umm Kulthum” competition will even be held to find new voices who “embody the spirit of the legendary artist.”
Islam Elkholi retweeted
🚨 New correspondence in Nature! 🚨I argue for bigger increases to CIHR investigator-initiated grants, because bigger operating budgets = better stipends for research trainees across 🇨🇦.
nature.com/articles/d41586-0…
Islam Elkholi retweeted
🚨 Exciting Opportunity Alert! 🚨
Are you passionate about understanding why cancer patients relapse and uncovering the secrets of tumor dormancy and metastasis?
Join our dynamic lab @FoxChaseCancer @templemedschool!
We're looking for a postdoc to join our mission of tackling cancer relapse and metastasis.
📩 Email or DM me to apply! Let’s push the boundaries of cancer biology together.
✨ Please RT to spread the word! ✨


































